Shandong Boyuan Pharmaceutical & Chemical Co., Ltd.: what insiders have been doing
Insider filings for Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. are scarce in the SSE / SZSE (CSRC) feed, the latest one published on 2 July 2026. This page will fill in as new trades are disclosed. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€1M
1 ops. · all time
Who traded when
BuySale
潍坊智硕投资合伙企业(有限合伙)1 sale
Nov 24May 25Nov 25May 26
Top signal score 15 of 100
Buys n/a€1M Sells
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 13,652 of 23,476 companies
46.8
score / 100
Value
28
Quality
65
FCF yld-1.0%
Earn yld2.0%
EV/EBITDA36.8x
ROE9.8%
Gross mgn20%
Net mgn12%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
214,500 shares@ CN¥417.2287100.0% of flowA股XSHESZSE:273000000791501380
1 of 1 declaration
About Shandong Boyuan Pharmaceutical & Chemical Co., Ltd.
博苑新材 is a company listed on the XSHE market, specializing in new materials. It focuses on the development and production of innovative solutions for various sectors.